Literature DB >> 1999009

Arginine restores cholinergic relaxation of hypercholesterolemic rabbit thoracic aorta.

J P Cooke1, N A Andon, X J Girerd, A T Hirsch, M A Creager.   

Abstract

BACKGROUND: Reduced synthesis of endothelium-derived relaxing factor (EDRF) may explain impaired endothelium-dependent vasodilation in hypercholesterolemia. Accordingly, we designed studies to determine if endothelium-dependent relaxation in hypercholesterolemic rabbits may be restored by supplying L-arginine, the precursor of EDRF. METHODS AND
RESULTS: Normal or hypercholesterolemic rabbits received intravenous L-arginine (10 mg/kg/min) or vehicle for 70 minutes. Subsequently, animals were killed, thoracic aortas were harvested, and vascular rings were studied in vitro. Rings were contracted by norepinephrine and relaxed by acetylcholine chloride or sodium nitroprusside. Vasorelaxation was quantified by determining the maximal response (expressed as percent relaxation of the contraction) and the ED50 (dose of drug inducing 50% relaxation; expressed as -log M). In vessels from hypercholesterolemic animals receiving vehicle, there was a fivefold rightward shift in sensitivity to acetylcholine compared with normal animals (p = 0.05, n = 5 in each group). In vessels from hypercholesterolemic animals, L-arginine augmented the maximal response to acetylcholine (83 +/- 16% versus 60 +/- 15%, p = 0.04 versus vehicle) and increased the sensitivity to acetylcholine (ED50 value: 6.7 +/- 0.2 versus 6.2 +/- 0.2, p less than 0.05 versus vehicle). Arginine did not affect maximal and EC50 responses to acetylcholine in vessels from normal animals. Arginine did not potentiate endothelium-independent responses in either group.
CONCLUSIONS: We conclude that the endothelium-dependent relaxation is normalized in hypercholesterolemic rabbit thoracic aorta by in vivo exposure to L-arginine, the precursor for EDRF.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1999009     DOI: 10.1161/01.cir.83.3.1057

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  41 in total

1.  Effects of L-arginine on flow mediated dilatation induced by atrial pacing in diseased epicardial coronary arteries.

Authors:  D Tousoulis; G J Davies; C Tentolouris; T Crake; G Goumas; C Stefanadis; P Toutouzas
Journal:  Heart       Date:  2003-05       Impact factor: 5.994

2.  Oxidative modification of low-density lipoproteins and the inhibition of relaxations mediated by endothelium-derived nitric oxide in rabbit aorta.

Authors:  F Plane; K R Bruckdorfer; P Kerr; A Steuer; M Jacobs
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

3.  Abolition of flow-dependent EDRF release before that evoked by agonists in hypercholesterolaemic rabbits.

Authors:  I R Hutcheson; J A Smith; T M Griffith
Journal:  Br J Pharmacol       Date:  1994-09       Impact factor: 8.739

Review 4.  Control of coronary blood flow by autacoids.

Authors:  E Bassenge
Journal:  Basic Res Cardiol       Date:  1995 Mar-Apr       Impact factor: 17.165

Review 5.  Role of nitric oxide in progression and regression of atherosclerosis.

Authors:  J P Cooke
Journal:  West J Med       Date:  1996-05

Review 6.  Cellular and molecular mechanisms of endothelial cell dysfunction.

Authors:  D G Harrison
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

7.  Overexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE-deficient mice.

Authors:  Masanori Ozaki; Seinosuke Kawashima; Tomoya Yamashita; Tetsuaki Hirase; Masayuki Namiki; Nobutaka Inoue; Ken-ichi Hirata; Hiroyuki Yasui; Hiromu Sakurai; Yuichi Yoshida; Masahiro Masada; Mitsuhiro Yokoyama
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

8.  Interaction of the endothelial nitric oxide synthase with the CAT-1 arginine transporter enhances NO release by a mechanism not involving arginine transport.

Authors:  Chunying Li; Wei Huang; M Brennan Harris; Jonathan M Goolsby; Richard C Venema
Journal:  Biochem J       Date:  2005-03-15       Impact factor: 3.857

9.  Superoxide and peroxynitrite in atherosclerosis.

Authors:  C R White; T A Brock; L Y Chang; J Crapo; P Briscoe; D Ku; W A Bradley; S H Gianturco; J Gore; B A Freeman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

10.  Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit.

Authors:  J P Cooke; A H Singer; P Tsao; P Zera; R A Rowan; M E Billingham
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.